Report Type: Therapy Reports
Report Category: Blood Diseases
Report Subcategory: Hemophilia A or Factor VIII Deficiency
Price: 2999.00
Date: December 2021

Hemophilia A or Factor VIII Deficiency: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Hemophilia A or Factor VIII Deficiency
Hemophilia A is also known to be Factor VIII which is a clotting protein. Hemophilia A or Factor VIII Deficiency is a genetic disorder in which deficiency of clotting protein (Factor VIII) is observed, due to this deficiency a hemophilic or bleeding condition is resulted.

Top 10 Companies:
F. Hoffmann-La Roche Ltd
Pfizer Inc
Bayer AG
Takeda Pharmaceutical Co Ltd
Novo Nordisk AS
Teva Pharmaceutical Industries Ltd
Biogen Inc
Baxter International Inc
Daiichi Sankyo Co Ltd
CSL Ltd